Melanoma on Chronically Sun-Damaged Skin: Deciphering Gene Expression Signatures
Keywords:
Melanoma, Gene Expression, Ultraviolet Radiation, Sequence Analysis RNA, Inflammation,Abstract
Introduction: Melanoma of the skin is responsible for most skin cancer-related deaths. It is well known that exposure to ultraviolet radiation is the most common and modifiable risk factor for melanoma. Melanomas arising on chronically sun-damaged skin have shown a higher mutational burden.
Objective: We sought to analyze skin samples of patients with melanoma on chronically sun-damaged skin (CSDS) to identify possible gene expression signatures that may contribute to melanomagenesis.
Methods: Design: Experimental. Participants: A total of 10 subjects with a newly diagnosed melanoma on CSDS. Eligibility criteria included patients older than 18 years old with a recent diagnosis of melanoma on CSDS. Intervention: For each patient, 2 skin samples were obtained using a 2-mm punch (1 from CSDS within 2 cm of the primary melanoma, another from sun-protected skin). Skin samples were sent to the Sylvester Onco-genomics Core for library preparation and RNA sequencing. Main Outcomes: Identification of differentially expressed genes between CSDS and non-CSDS of melanoma patients.
Results: Significant differences were observed between the CSDS and non-CSDS samples. Pathways involved in inflammation (e.g., IL-17 signaling), immune responses (e.g., ABC transporters), and oxidative phosphorylation were overexpressed in CSDS.
Conclusions: CSDS can be an adequate milieu for the development and progression of melanoma. CSDS reveals overexpression of pathways involved in inflammation, immune responses, and oxidative phosphorylation, which may facilitate interactions between the skin microenvironment and melanocytes/melanoma cells, predisposing to melanoma development and progression.
References
Pecorelli A, Valacchi G. Oxidative-stress-sensitive microRNAs in UV-promoted development of melanoma. Cancers (Basel). 2022;14(13):3224. DOI: 10.3390/cancers14133224.
Millán-Esteban D, Peña-Chilet M, Garcia-Casado Z, et al. Mutational characterization of cutaneous melanoma supports divergent pathways model for melanoma development. Cancers (Basel). 2021;13(20):5219. DOI: 10.3390/cancers13205219.
Sanna A, Harbst K, Johansson I, et al. Tumor genetic heterogeneity analysis of chronic sun-damaged melanoma. Pigment Cell Melanoma Res. 2020;33(3):480–89. DOI: 10.1111/pcmr.12851.
Wu T, Hu E, Xu S, et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation (Camb). 2021;2(3):100141. DOI: 10.1016/j.xinn.2021.100141.
Guo Y, Zhao S, Ye F, Sheng Q, Shyr Y. MultiRankSeq: multiperspective approach for RNAseq differential expression analysis and quality control. Biomed Res Int. 2014;2014:248090. DOI: 10.1155/2014/248090.
Chhabra Y, Weeraratna AT. Fibroblasts in cancer: unity in heterogeneity. Cell. 2023;186(8):1580–609. DOI: 10.1016/j.cell.2023.03.016.
Moon H, Donahue LR, Choi E, et al. Melanocyte stem cell activation and translocation initiate cutaneous melanoma in response to UV exposure. Cell Stem Cell. 2017;21(5):665–78.e6. DOI: 10.1016/j.stem.2017.09.001.
Zhang X, Tai Z, Miao F, et al. Metabolism heterogeneity in melanoma fuels deactivation of immunotherapy: predict before protect. Front Oncol. 2022;12:1046102. DOI: 10.3389/fonc.2022.1046102.
Klotz L, Burgdorf S, Dani I, et al. The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity. J Exp Med. 2009;206(10):2079–89. DOI: 10.1084/jem.20082771.
Mandinova A, Lefort K, Tommasi di Vignano A, et al. The FoxO3a gene is a key negative target of canonical Notch signalling in the keratinocyte UVB response. Embo j. 2008;27(8):1243–1254. DOI: 10.1038/emboj.2008.45.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Alejandra Avila, Varsha Thakur, Natalie Vincent, Pilar Valencia, Mecker Möller, Rimpi Khurana, Guo Yan, Jennifer C. Tang, Barbara Bedogni, Natalia Jaimes

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.